Pathstone Family Office’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Pathstone Family Office’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,334,754	Closed	-$2.35M	–	1568
2022 Q4	$2.35M	Buy	5,334,754 +1,251,324	+31%	+$574K	0.02%	459
2022 Q3	$5.31M	Buy	4,083,430 +4,042,095	+9,779%	+$8.6M	0.05%	221
2022 Q2	$61.6K	Buy	41,335 +30,678	+288%	+$141K	﹤0.01%	1012
2022 Q1	$87K	Buy	+10,657	New	+$94.1K	﹤0.01%	929

Other funds holding CORZ

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

CWC

Carolinas Wealth Consulting Charlotte, North Carolina $465M AUM 8.53% 1-Year Est. Return

BWP

BSW Wealth Partners Boulder, Colorado $899M AUM 28.56% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

PCA

Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Pathstone Family Office's CORZ Position: Q1 2023 in Review

Pathstone Family Office sold out of Core Scientific, Inc. Common Stock (CORZ) in Q1 2023, closing a stake of 5,334,754 shares — an estimated $2.35M sold.

Pathstone Family Office first reported a position in CORZ in Q1 2022 and held it in 4 quarters. The position peaked at $5.31M in Q3 2022. 10 funds tracked by Wall St. Rank hold CORZ as of Q1 2023.

Pathstone Family Office reported no remaining Core Scientific, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Pathstone Family Office sold 5,334,754 Core Scientific, Inc. Common Stock shares in Q1 2023, an estimated $2.35M.
Pathstone Family Office first reported a position in Core Scientific, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Pathstone Family Office's Core Scientific, Inc. Common Stock position peaked at $5.31M in Q3 2022.
10 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q1 2023.

Based on Pathstone Family Office's 13F filing for Q1 2023, filed 15 May 2023.